HI
GILD icon

HBK Investments’s Gilead Sciences GILD Stock Holding History

HBK Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,459
Closed -$365K – 871
2021
Q1 		$353K Sell
5,459
-22,258
-80% -$1.44M ﹤0.01% 690
2020
Q4 		$1.61M Sell
27,717
-435
-2% -$26.2K 0.01% 450
2020
Q3 		$1.78M Sell
28,152
-271
-1% -$18.8K 0.01% 368
2020
Q2 		$2.19M Buy
+28,423
New +$2.18M 0.03% 293
2019
Q3 		– Sell
-51,497
Closed -$3.48M – 679
2019
Q2 		$3.48M Sell
51,497
-308,218
-86% -$20.3M 0.03% 291
2019
Q1 		$23.4M Buy
359,715
+110,890
+45% +$7.37M 0.24% 64
2018
Q4 		$15.6M Buy
248,825
+107,425
+76% +$7.51M 0.17% 93
2018
Q3 		$10.9M Sell
141,400
-34,400
-20% -$2.6M 0.09% 137
2018
Q2 		$12.5M Sell
175,800
-173,209
-50% -$12.2M 0.08% 144
2018
Q1 		$26.3M Buy
349,009
+163,209
+88% +$13M 0.18% 55
2017
Q4 		$13.3M Buy
+185,800
New +$14.1M 0.1% 121
2017
Q3 		– Sell
-524,100
Closed -$37.1M – 1050
2017
Q2 		$37.1M Sell
524,100
-19,100
-4% -$1.27M 0.23% 55
2017
Q1 		$36.9M Buy
543,200
+93,816
+21% +$6.6M 0.3% 60
2016
Q4 		$32.2M Buy
449,384
+223,207
+99% +$16.6M 0.31% 66
2016
Q3 		$17.9M Buy
226,177
+109,131
+93% +$8.87M 0.16% 99
2016
Q2 		$9.76M Sell
117,046
-99,592
-46% -$8.84M 0.07% 159
2016
Q1 		$19.9M Sell
216,638
-99,562
-31% -$8.98M 0.19% 77
2015
Q4 		$32M Buy
316,200
+48,477
+18% +$5.04M 0.29% 47
2015
Q3 		$26.3M Buy
267,723
+261,523
+4,218% +$29M 0.26% 55
2015
Q2 		$726K Sell
6,200
-1,700
-22% -$186K 0.01% 641
2015
Q1 		$775K Buy
+7,900
New +$802K 0.01% 626
2014
Q4 		– Sell
-139,908
Closed -$14.9M – 1033
2014
Q3 		$14.9M Buy
+139,908
New +$13.7M 0.23% 76

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HBK Investments's GILD Position: Q2 2021 in Review

HBK Investments sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 5,459 shares — an estimated $365K sold.

HBK Investments first reported a position in GILD in Q3 2014 and held it in 22 quarters. The position peaked at $37.1M in Q2 2017. 1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • HBK Investments reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
  • HBK Investments sold 5,459 Gilead Sciences shares in Q2 2021, an estimated $365K.
  • HBK Investments first reported a position in Gilead Sciences in Q3 2014 and held it in 22 quarters.
  • HBK Investments's Gilead Sciences position peaked at $37.1M in Q2 2017.
  • 1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on HBK Investments's 13F filing for Q2 2021, filed 16 Aug 2021.